DCTHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

DELCATH SYSTEMS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$14.37+0.29 (+2.06%)

Close on Oct 19, 2026

Market cap: $571.37M
P/E (TTM): 1437.0
Dividend yield: –

DELCATH SYSTEMS, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	85	37	2.07	2.72	3.56	–	–	–	2.72	1.99	1.75	1.07	0.79	0.35	0	0	–
Cost of Revenue	12	6.19	0.64	0.69	0.67	0.64	0.72	1.01	0.70	0.55	0.46	0.29	0.46	0.04	0	0	–
Gross Profit	73	31	1.43	2.03	2.88	1.01	0.86	2.40	2.01	1.44	1.29	0.78	0.33	0.31	0	0	–
Research & Development	29	14	18	19	14	11	9.49	20	10	8.45	6.49	4.30	13	26	25	18	9.64
Selling, General & Admin	44	30	22	17	14	11	11	9.82	9.68	9.43	10	16	21	28	21	13	–
General & Administrative	–	–	–	–	–	–	–	–	–	–	–	–	–	–	21	13	3.90
Operating Expenses	73	43	40	36	27	22	21	29	20	18	16	20	33	–	–	–	–
Total Costs & Expenses	–	–	–	–	–	–	–	–	–	–	–	20	33	54	46	31	14
Operating Income	0.66	-12	-38	-34	-25	-21	-20	-27	-18	-16	-15	-19	-33	-54	-46	-31	-14
Interest Expense	–	–	–	–	–	–	–	–	22	14	0.07	–	–	–	–	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	0.02	0.01	0.01	0.02	0.02	0.01	0.01	0.07
Other Non-Operating Income	-0.07	-0.03	-0.06	0.03	0.07	0.15	0.00	0.05	-0.04	0.02	0.01	-0.02	-0.08	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	0	-0.02	0.00	-0.02	-0.28	-0.01	–	–	–	–
Pretax Income	3.51	-26	-48	-37	-26	-24	-8.88	-19	-45	-18	-15	-17	-30	–	–	–	–
Income Tax Expense	0.81	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	-26	-24	–	-19	-45	–	–	–	–	–	–	–	–
Minority Interest in Earnings	–	–	–	–	–	24	8.88	–	–	–	–	–	–	–	–	–	–
Net Income	2.70	-26	-48	-37	-26	-24	-8.88	-19	-45	-18	-15	-17	-30	-52	-31	-47	-22
Preferred Dividends	–	–	–	–	–	–	–	–	0.53	–	–	–	–	–	–	–	–
Net Income to Common	–	–	–	–	-26	-24	–	-19	-46	-18	-15	-17	-32	-52	-31	–	–
EPS (Basic)(per share)	0.08	-0.93	-2.94	-4.12	-3.59	-8.35	-342.83	-504.00	-3,250.00	-3,707.00	-5,096.00	-10,304.00	-26,936.00	-75,824.00	-60,928.00	-107,520.00	-73,472.00
EPS (Diluted)(per share)	0.07	-0.93	-2.94	-4.12	-3.59	-8.35	-342.83	-504.00	-3,250.00	-3,707.00	-5,096.00	-10,304.00	-28,560.00	-75,824.00	-60,928.00	-107,520.00	-73,472.00
Shares Outstanding (Basic, Weighted)(shares)	36	29	16	8.86	7.15	2.90	0.03	0.04	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–
Shares Outstanding (Diluted, Weighted)(shares)	40	29	16	8.86	7.15	2.90	0.03	0.04	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 87.1%
Operating margin: -1.9%
Net margin: 0.6%
Return on equity, FY2025: 3.0%

Financial strength

Current ratio: 9.83
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 357.9%

Valuation

P/E ratio: 1437.0
Price to sales: 5.99
Price to book: 4.72
Dividend yield: –